Log in

OTCMKTS:LIXT - Lixte Biotechnology Stock Price, Forecast & News

0.00 (0.00 %)
(As of 01/24/2020 04:00 PM ET)
Today's Range
Now: $0.70
50-Day Range
MA: $0.76
52-Week Range
Now: $0.70
Volume2,300 shs
Average Volume3,700 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primary focuses on developing various treatments for human cancers and other non-malignant diseases, including vascular diseases, such as heart attacks and strokes, and diabetes, as well as genetic diseases comprising Gaucher's disease; and depression and post-traumatic stress syndrome. It develops protein phosphatase inhibitors that include LB-100 series of compounds; and histone deacetylase inhibitors, which comprises LB-200 series of compounds for the treatment of cancer, as well as in the prevention and treatment of neurodegenerative diseases, which are under various stages of pre-clinical and clinical developments. The company was founded in 2005 and is based in East Setauket, New York.

Industry, Sector and Symbol

Industry Biotechnology
Current SymbolOTCMKTS:LIXT
Previous SymbolNASDAQ:LIXT



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive LIXT News and Ratings via Email

Sign-up to receive the latest news and ratings for LIXT and its competitors with MarketBeat's FREE daily newsletter.

Lixte Biotechnology (OTCMKTS:LIXT) Frequently Asked Questions

What is Lixte Biotechnology's stock symbol?

Lixte Biotechnology trades on the OTCMKTS under the ticker symbol "LIXT."

How were Lixte Biotechnology's earnings last quarter?

Lixte Biotechnology Holdings Inc (OTCMKTS:LIXT) posted its quarterly earnings data on Friday, November, 4th. The company reported ($0.01) EPS for the quarter. View Lixte Biotechnology's Earnings History.

Has Lixte Biotechnology been receiving favorable news coverage?

Press coverage about LIXT stock has been trending extremely negative on Saturday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Lixte Biotechnology earned a news sentiment score of -4.5 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Lixte Biotechnology.

Who are some of Lixte Biotechnology's key competitors?

What other stocks do shareholders of Lixte Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lixte Biotechnology investors own include CVR Refining (CVRR), Guyana Goldfields (GUY), Ensign Energy Services (ESVIF), Yuma Energy (YUMA), Weyerhaeuser (WY), Pretium Resources (PVG), Plains GP (PAGP), CVR Energy (CVI), Callon Petroleum (CPE) and Amicus Therapeutics (FOLD).

Who are Lixte Biotechnology's key executives?

Lixte Biotechnology's management team includes the folowing people:
  • Dr. John S. Kovach, Founder, Chairman, Pres, CEO & CFO (Age 82)
  • Mr. Gil N. Schwartzberg, Consultant
  • Dr. Francis Johnson Ph.D., Consultant

How do I buy shares of Lixte Biotechnology?

Shares of LIXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Lixte Biotechnology's stock price today?

One share of LIXT stock can currently be purchased for approximately $0.70.

What is Lixte Biotechnology's official website?

The official website for Lixte Biotechnology is http://www.lixte.com/.

How can I contact Lixte Biotechnology?

Lixte Biotechnology's mailing address is 248 Route 25A, No. 2, EAST SETAUKET, NY 11733, United States. The company can be reached via phone at +1-631-8307092.

MarketBeat Community Rating for Lixte Biotechnology (OTCMKTS LIXT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  50 (Vote Underperform)
Total Votes:  104
MarketBeat's community ratings are surveys of what our community members think about Lixte Biotechnology and other stocks. Vote "Outperform" if you believe LIXT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LIXT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel